Exhibit 99.1
PRESS RELEASE
FOR IMMEDIATE RELEASE
March 13, 2002
Emergisoft Announces Reverse Stock Split
----------------------------------------
Arlington, Texas - (March 13, 2002)
Emergisoft Holding, Inc. (OTC:ESHI) announced today that it will decrease
the number of common stock shares it is authorized to issue from 750,000,000 to
37,500,000 to be effective on March 31, 2002. Correspondingly, Emergisoft will
effectuate a 20-for-1 reverse stock split of its outstanding shares of common
stock. The total current number of the company's issued and outstanding shares
of common stock is 199,097,069. Following the reverse split, the total number of
outstanding shares of common stock will be 9,954,854.
Dan Witte, Chief Executive Officer and President of Emergisoft said, "The
Board of Directors felt this action was necessary to position the company for
its future capital needs and to make the company's stock more attractive in the
current trading market. Improved access to capital will help achieve the
anticipated growth of the company."
About Emergisoft Corporation
Arlington, Texas-based Emergisoft Corporation (OTC:ESHI) is a leader in the
design and implementation of clinical patient management systems for hospital
Emergency Department automation across the United States. Their newest release,
CareLyncEDTM, was designed to eliminate the time consuming collection of
repetitive clinical data. The one-of-a-kind, professional grade, open system
software, uses cutting edge technology and graphics to streamline patient
documentation, protect against errors and litigation, fulfill government
compliance, optimize revenue recovery and control physician and nurse cost and
charges. For additional information about Emergisoft and CareLyncEDTM, please
visit Emergisoft on the Internet at www.emergisoft.com.
************Contact: Vicki Judd Ann Crossman
Emergisoft or Emergisoft
817-633-6665 817-633-6665
vjudd@emergisoft.com acrossman@emergisoft.com
The statements in this press release regarding projections of revenues or
income or similar items, such as statements pertaining to future revenues,
future cash flows, future operations or results, and other statements that are
not historical facts, are forward looking statements. Such statements involve
risks relating to technological change and new product development, quality
assurance and product acceptance concerns, competition for customers, government
regulation and other factors detailed in the Company's filings with the
Securities and Exchange Commission. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove incorrect,
actual outcomes may vary materially from those indicated.